Citation Impact
Citing Papers
Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix
2006 Standout
British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE
2013 Standout
EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-β signaling in lung fibroblasts
2006 StandoutNobel
Formation and Function of the Myofibroblast during Tissue Repair
2007 Standout
Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF: association with altered surfactant protein processing and herpesvirus infection
2008
Idiopathic pulmonary fibrosis
2017 Standout
Cyclooxygenase-2 Deficiency Results in a Loss of the Anti-Proliferative Response to Transforming Growth Factor-β in Human Fibrotic Lung Fibroblasts and Promotes Bleomycin-Induced Pulmonary Fibrosis in Mice
2001
Intrapleural Streptokinase in the Management of Malignant Multiloculated Pleural Effusions
1999
Cellular and molecular mechanisms of fibrosis
2007 Standout
Pulmonary infection in Wegener granulomatosis and idiopathic pulmonary fibrosis
2009
A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
2014 Standout
U.K. Controlled Trial of Intrapleural Streptokinase for Pleural Infection
2005 Standout
Murine models of pulmonary fibrosis
2007
Wound repair and regeneration
2008 StandoutNature
Pulmonary fibrosis: pathogenesis, etiology and regulation
2009 Standout
The pathogenesis of cardiac fibrosis
2013 Standout
Laparoscopic anti-reflux surgery for idiopathic pulmonary fibrosis at a single centre
2016
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
Macrophages: Master Regulators of Inflammation and Fibrosis
2010 Standout
BTS guidelines for the management of pleural infection in children
2005 Standout
TGF-β-induced EMT: mechanisms and implications for fibrotic lung disease
2007 Standout
Epstein–Barr virus load monitoring: its role in the prevention and management of post‐transplant lymphoproliferative disease
2001
Herpesviruses and the transplanted lung: Looking at the air side
2008
Empirical treatment with fibrinolysis and early surgery reduces the duration of hospitalization in pleural sepsis
1999
Pirfenidone in idiopathic pulmonary fibrosis
1999
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
2011 Standout
Twist: A Regulator of Epithelial-Mesenchymal Transition in Lung Fibrosis
2009
Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
2019 Standout
Randomised trial of intrapleural urokinase in the treatment of childhood empyema
2002
Tuberculosis and lung damage: from epidemiology to pathophysiology
2018 StandoutNobel
Interstitial lung disease guideline
2008
Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases
2007 Standout
Fibrotic disease and the TH1/TH2 paradigm
2004 Standout
Role of Epithelial Cells in Idiopathic Pulmonary Fibrosis: From Innocent Targets to Serial Killers
2006
Management of pleural infection in adults: British Thoracic Society pleural disease guideline 2010
2010 Standout
Acute respiratory distress syndrome
2019 Standout
Involvement of Epstein-Barr virus latent membrane protein 1 in disease progression in patients with idiopathic pulmonary fibrosis
2000
Idiopathic pulmonary fibrosis
2017 Standout
Medical and Surgical Treatment of Parapneumonic Effusions
2000 Standout
BTS guidelines for the management of pleural infection
2003
Idiopathic Pulmonary Fibrosis
2004
Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis
2009
Prevention of infections in solid organ transplant recipients
1999
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
2012 Standout
Alternative Activation of Macrophages: Mechanism and Functions
2010 Standout
Pirfenidone in idiopathic pulmonary fibrosis
2009 Standout
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
2018 Standout
Idiopathic Pulmonary Fibrosis
2001 Standout
Respiratory viral infection: a potential “missing link” in the pathogenesis of COPD
2019
Studies of Murine Schistosomiasis Reveal Interleukin–13 Blockade As A Treatment for Established and Progressive Liver Fibrosis
2001
New treatments for pulmonary fibrosis?
1999
Idiopathic pulmonary fibrosis
2011 Standout
Emerging cellular and molecular determinants of idiopathic pulmonary fibrosis
2020
The Myofibroblast
2007 Standout
Animal models of acute lung injury
2008 Standout
Incidence and Prevalence of Idiopathic Pulmonary Fibrosis
2006 Standout
Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis
2010 Standout
Intrapleural Urokinase versus Normal Saline in the Treatment of Complicated Parapneumonic Effusions and Empyema
1999
Activation of Alveolar Macrophages via the Alternative Pathway in Herpesvirus-Induced Lung Fibrosis
2006
Idiopathic Pulmonary Fibrosis: A Genetic Disease That Involves Mucociliary Dysfunction of the Peripheral Airways
2016
Multicenter quality control study for human cytomegalovirus DNAemia quantification.
2009
Herpesvirus DNA Is Consistently Detected in Lungs of Patients with Idiopathic Pulmonary Fibrosis
2003
Clinical practice guidelines for antimicrobial prophylaxis in surgery
2013 Standout
Infectious disease, the innate immune response, and fibrosis
2007
Mechanisms of Pulmonary Fibrosis
2004
β-Arrestin Deficiency Protects Against Pulmonary Fibrosis in Mice and Prevents Fibroblast Invasion of Extracellular Matrix
2011 StandoutNobel
Plasma membrane wounding and repair in pulmonary diseases
2017
Murine gammaherpesvirus-induced fibrosis is associated with the development of alternatively activated macrophages
2008
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?
2019 Standout
Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy
2001 Standout
Relationship between Cytomegalovirus DNA Load in Epithelial Lining Fluid and Plasma of Lung Transplant Recipients and Analysis of Coinfection with Epstein-Barr Virus and Human Herpesvirus 6 in the Lung Compartment
2006
Non-steroid agents for idiopathic pulmonary fibrosis
2010
Alternative Activation of Macrophages: An Immunologic Functional Perspective
2008 Standout
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyema
2008
Hypoxia-Inducible Factor 1α Is a Critical Downstream Mediator for Hypoxia-Induced Mitogenic Factor (FIZZ1/RELMα)–Induced Pulmonary Hypertension
2015 StandoutNobel
Mechanisms of Renal Fibrosis
2017 Standout
ELMOD2 , a candidate gene for idiopathic pulmonary fibrosis, regulates antiviral responses
2009
Idiopathic Pulmonary Fibrosis
2018 Standout
Role of Extracellular Matrix in Adaptation of Tendon and Skeletal Muscle to Mechanical Loading
2004 Standout
Integrating mechanisms of pulmonary fibrosis
2011 Standout
Works of She Lok being referenced
Epstein–Barr virus and wild p53 in idiopathic pulmonary fibrosis
2001
Interstitial lung disease clinics for the management of idiopathic pulmonary fibrosis: a potential advantage to patients
1999
Murine gammaherpes virus as a cofactor in the development of pulmonary fibrosis in bleomycin resistant mice
2002
Idiopathic Pulmonary Fibrosis and Cyclosporine
1998
PREEMPTIVE TREATMENT FOR THE PREVENTION OF CYTOMEGALOVIRUS DISEASE
1998
The Detection of Epstein-Barr Virus DNA in Lung Tissue from Patients with Idiopathic Pulmonary Fibrosis
1999
A Rearranged Form of Epstein–Barr Virus DNA Is Associated with Idiopathic Pulmonary Fibrosis
2002
The Systemic Fibrinolytic Activity of Intrapleural Streptokinase
1998
Viruses and idiopathic pulmonary fibrosis.
2000